PPH
ヴァンエック・製薬ETF
PPH
ヴァンエック・製薬ETF
$ 111.5
-
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
| Ticker | Company | Weight |
|---|---|---|
| LLY | Eli Lilly and Company | 18.73% |
| NVS | Novartis AG ADR | 11.13% |
| MRK | Merck & Company Inc | 9.71% |
| JNJ | Johnson & Johnson | 5.02% |
| MCK | McKesson Corporation | 4.98% |
| PFE | Pfizer Inc | 4.96% |
| BMY | Bristol-Myers Squibb Company | 4.93% |
| GSK | GlaxoSmithKline PLC ADR | 4.81% |
| NVO | Novo Nordisk A/S | 4.78% |
| AZN | AstraZeneca PLC | 4.49% |
| 銘柄 | 株価 | 配当利回り |
|---|